50% - 75% of children with neurodevelopmental or psychiatric comorbidities such as ASD may experience paediatric insomnia.
The sleep disturbances exacerbate both cognitive performance deficits and behavioural problems and subsequently cause entire-family distress. Long-term sleep disorders, and the resulting day and night care difficulties, are among the main factors affecting parental decisions on whether, and when, to institutionalise their child.4
Increasing evidence demonstrates the compounding effect of sleep problems on autism symptomatology.
Poor sleep also predicts later anxiety difficulties both in neurotypical and ASD children.
A free to access sleep and nap diary app (SNappD) developed by Flynn Pharma can be used to record and report sleep and nap statistics.
4. De Leersnyder, H. et al. Prolonged-Release Melatonin for Children With Neurodevelopmental Disorders. Paediatric Neurology. 2011;45(1):23-6.
5. Deliens, G. et al. Sleep Disturbance in Autism Spectrum Disorders. Rev J Autism Dev Disorder. 2015; 2:343-356
6. Maras, A. et al., Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 2018; 1-12
7. Delahaye, J. et al., The relationship between Health-Related Quality of Life and sleep problems in children with autism spectrum disorders. Research in Autistic Spectrum Disorders. 2014;8(3):292-303
8. Schroder, C M. et al., Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behaviour and Care Giver’s Quality of Life. Journal of Autism and Developmental Disorders. 2019; 1-13